marginally significantP = .031
168 , 169 The Cochrane meta-analysis (n = 1039) found marginally significant lower 12-month relapse rates with omega-3 fatty acids over placebo (39% vs 47%; RR, 0.77; 95% CI, 0.61–0.98; P = .031).
168 , 169 The Cochrane meta-analysis (n = 1039) found marginally significant lower 12-month relapse rates with omega-3 fatty acids over placebo (39% vs 47%; RR, 0.77; 95% CI, 0.61–0.98; P = .031).